We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

70 hedge funds and large institutions have $335M invested in La Jolla Pharmaceutical Company in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more call options, than puts

Call options by funds: $1.49M | Put options by funds: $585K

127% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 15

13% less funds holding

Funds holding: 80 → 70 (-10)

23% less capital invested

Capital invested by funds: $434M → $335M (-$98.8M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
70
Holders Change
-10
Holders Change %
-12.5%
% of All Funds
1.87%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
34
Reduced
15
Closed
18
Calls
$1.49M
Puts
$585K
Net Calls
+$903K
Net Calls Change
+$571K

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$9.93M
2
Jennison Associates
Jennison Associates
New York
+$4.43M
3
JHIU
Janus Henderson Investors US
Colorado
+$3.51M
4
TCM
Tang Capital Management
California
+$3.21M
5
RI
RTW Investments
New York
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$10.2M
2
State Street
State Street
Massachusetts
-$4.33M
3
OM
Opaleye Management
Massachusetts
-$3.78M
4
IHM
Iguana Healthcare Management
New York
-$2.97M
5
ACP
Acuta Capital Partners
California
-$2.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.02M +$20.9K +1,170 +2%
AAM
27
Advisors Asset Management
Colorado
$899K +$350K +19,609 +84%
TCIM
28
TIAA CREF Investment Management
New York
$869K – – –
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$780K – – –
TAM
30
Tocqueville Asset Management
New York
$761K +$107K +6,000 +20%
Deutsche Bank
31
Deutsche Bank
Germany
$733K -$1.83M -102,701 -75%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$610K +$65K +3,644 +14%
Swiss National Bank
33
Swiss National Bank
Switzerland
$493K +$78.5K +4,400 +22%
TA
34
Teachers Advisors
New York
$481K – – –
GCP
35
GSA Capital Partners
United Kingdom
$470K +$401K +22,500 New
Millennium Management
36
Millennium Management
New York
$464K +$396K +22,202 New
HCM
37
Hollencrest Capital Management
California
$462K – – –
Charles Schwab
38
Charles Schwab
California
$452K – – –
EMG
39
Ellington Management Group
Connecticut
$345K +$294K +16,500 New
Goldman Sachs
40
Goldman Sachs
New York
$329K +$87.1K +4,885 +45%
Squarepoint
41
Squarepoint
New York
$303K +$259K +14,500 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$299K +$18.5K +1,040 +8%
NPC
43
National Planning Corporation
California
$289K -$8.92K -500 -3%
BBA
44
Baker Bros. Advisors
New York
$287K – – –
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$284K – – –
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$279K +$80.6K +4,521 +51%
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
$264K +$225K +12,630 New
UBS Group
48
UBS Group
Switzerland
$261K -$453K -25,423 -67%
Citigroup
49
Citigroup
New York
$248K +$178K +9,961 +527%
Simplex Trading
50
Simplex Trading
Illinois
$214K +$119K +6,674 +186%
1
2
3 4

LJPC Hedge Fund Activity: Q1 2016 in Review

70 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q1 2016, worth a combined $335M — down 23% from $434M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of LJPC and 8 opened new positions — a net loss of 10 holders — while 15 trimmed existing stakes and 34 added.

The largest buyer was Visium Asset Management, adding an estimated $9.93M. The largest seller was Avoro Capital Advisors, cutting an estimated $10.2M.

  • 70 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q1 2016, down from 80 in Q4 2015.
  • Funds reported $335M of La Jolla Pharmaceutical Company stock for Q1 2016, down 23% quarter-over-quarter.
  • 8 funds opened new La Jolla Pharmaceutical Company positions in Q1 2016 and 18 closed out, a net change of -10 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q1 2016 was Visium Asset Management, an estimated $9.93M added.
  • The largest La Jolla Pharmaceutical Company seller in Q1 2016 was Avoro Capital Advisors, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2016.